Hospital Value Analysis Committee: How to Get Your Product Approved (2026)

A hospital value analysis committee (VAC) is the group that decides whether a new product, device, or technology is allowed into the hospital at all. It weighs clinical evidence, safety, cost, and fit with what the hospital already uses, then votes to approve, reject, or trial. For MedTech and health IT vendors, it's the gate between "the surgeon loves it" and an actual purchase order.

The part most sales teams miss: at many hospitals, you can't put your own product in front of the committee. Someone inside has to sponsor it, which changes who you reach, what you send, and how early you start.

This guide covers how value analysis works, what committees ask vendors for, and how to build the outbound motion that gets your product onto the agenda. If you sell devices, see how we book meetings with MedTech and medical device buyers.

What a value analysis committee actually does

Value analysis exists to keep product decisions evidence-based and to stop vendor sprawl. The committee compares your product with what's already on the shelf and asks whether the difference is worth the cost and the change.

The supply chain profession leans hard on independent evidence. AHRMM, the American Hospital Association's professional group for health care supply chain, supports comparative effectiveness research so value analysis teams can make purchasing decisions from objective data, standardize to a product formulary, and move to higher-cost products only when total cost goes down and quality measurably improves.

That direction is growing. In the 2024 GHX and AHVAP value analysis survey of 1,635 U.S. healthcare leaders, nearly 32% said their organizations primarily rely on evidence-based decision-making, up from almost 20% in 2023. The same survey found 41% of organizations have savings targets tied to their budgets.

A feature pitch doesn't survive this room. A cost and outcomes case does.

How the value analysis process works, step by step

Every hospital runs its own version, but the published workflows look alike. The University of Arkansas for Medical Sciences (UAMS) documents its process publicly, and it's a clean example:

Notice who presents in step 5. It's the sponsor, not the vendor.

symplr's hospital value analysis toolkit shows the same pattern in its sample workflow. Requests come from a physician or health system employee, with no external submissions permitted. The request then moves through sourcing, clinical, and finance review before a multidisciplinary team (clinical resource managers, supply chain directors, service line leaders, infection prevention, quality) evaluates it. Approved products that raise cost or lower revenue get another financial review.

What the committee will ask you for

Vendors still do much of the work, through the sponsor's request. The symplr toolkit's supplier checklist is a good preview of what you'll be asked. Have these ready before the first meeting:

• FDA clearance documentation, such as your 510(k) letter, when it applies
• All existing clinical evidence for the product
• Pricing, including tier information, and whether the product is already on contract
• Reimbursement information and CPT codes tied to the product
• References: other health systems that use it
• What it replaces, and how patient outcomes would differ from the current method
• Trial terms: whether a trial is available, and whether it carries any financial obligation
• Hidden dependencies: capital equipment, disposables, IT requirements, and infrastructure

If a sponsor has to chase you for any of this, your request sits. Package it as a ready-to-forward value analysis kit: a one-page summary, the evidence, the cost model, and the documents above. We cover that kit in the MedTech go-to-market playbook.

Why good products stall in value analysis

No sponsor, or the wrong one. If nobody inside owns the request, it never starts. A sponsor who won't use the product daily struggles to defend it.

A clinical pitch to a cost-and-risk committee. Value analysis committees care about standardization, safety, and total cost. Our guide to the healthcare buying committee explains why deals die when vendors bring a feature story to this stage.

Physicians aren't in the room. In the GHX and AHVAP survey, 85.11% of respondents reported "less than strong" physician engagement in value analysis. Your physician champion's enthusiasm doesn't help unless someone carries it to the committee. That's why you need more than one contact.

The committee calendar. UAMS reviews requests at monthly meetings. If your request misses one cycle because a form wasn't finished, you lose a month.

How to get your product onto the agenda

Value analysis is a sales problem before it's a paperwork problem. The work is finding the right people and arming them early.

1. Map the people around the committee, not just the economic buyer. For every target hospital, you want the likely clinical sponsor (the department chair, service line leader, or nurse leader whose team would use the product), the value analysis manager or clinical resource manager who runs the process, and the supply chain director. Most lists stop at the C-suite and the procurement VP, and even the contacts that are there are often unusable. In our healthcare prospect data report, only 2% of about 26,000 records across 55 client lists arrived complete.

2. Lead with the sponsor's problem. The sponsor isn't looking for a product. They're looking for a fix to something on their unit: a safety issue, a workflow that wastes hours, a cost line that's under scrutiny. Open with that, then show the evidence.

3. Multi-thread from day one. Reach the clinical sponsor and the value analysis lead in parallel, so the person who runs the process has heard of you before the request lands. A multichannel healthcare SDR cadence that mixes email, phone, and LinkedIn gives you more than one way into each person.

4. Make the sponsor's job easy. Send the value analysis kit before they ask. Offer to fill in the vendor long form the day it arrives. Ask when the next committee meeting is and work backward from that date.

5. Plan for a trial. Many committees approve a defined trial before full adoption. Know your trial terms, your success measures, and who will collect end-user feedback.

6. Track every account through the gate. Know which accounts have a sponsor, a request in, or a vote pending, so nothing goes quiet between meetings.

How Connexu helps you reach value analysis decision-makers

Connexu runs outbound for healthcare B2B companies, including MedTech, Health IT, and digital health vendors selling into health systems. For a value analysis motion, that means:

• Finding the buyers your list is missing. Our platform finds the hidden buyers at your target accounts that handed-over lists leave out.
• Experienced healthcare SDRs who run email, phone, and LinkedIn together and book meetings with sponsors and committee stakeholders. Learn how our outsourced healthcare SDR team works.
• Messaging built for the room: cost, safety, standardization, and outcomes, not just features. See our approach to MedTech lead generation and selling to health systems.

Frequently asked questions

What is a value analysis committee in a hospital? A value analysis committee is a multidisciplinary hospital or health system group that reviews requests for new products, devices, and technologies before they can be purchased. It typically weighs clinical evidence, safety, cost, reimbursement, and fit with products already in use, then approves, rejects, or approves a trial.

Can a vendor submit a product to a value analysis committee directly? Usually not. At many hospitals, a physician or employee has to start the request. symplr's sample workflow says no external submissions are permitted, and at UAMS a physician or clinician sponsor files the first form before the vendor rep is invited to complete the detailed one.

What documents does a value analysis committee need from vendors? Expect to provide clinical evidence, pricing with tier details, reimbursement information and CPT codes, references from other health systems, FDA clearance documentation such as a 510(k) letter when it applies, trial terms, and details on any capital, disposable, or IT requirements.

How long does value analysis approval take? There's no standard timeline. Committees often meet on a fixed schedule (UAMS meets monthly), and a request can go through several review steps and a trial before a final vote, so plan for more than one committee cycle.

How do you find the right sponsor for a value analysis request? Start with the leader whose team would use your product every day, such as a department chair, service line director, or nurse leader. Then identify the value analysis manager who runs the process, and reach both in parallel.

Ready to get in front of the people who decide?

Value analysis rewards vendors who reach the right sponsor early and show up with evidence. If you want a team that finds those people and books the meetings, book a meeting with Connexu. We'll show you who your current list is missing at your target hospitals.